Grant received in 2021
DCCC has funded 200,000 DKK to the project
Patients with metastatic cancer are considered incurable. However, some have limited numbers of metastases (oligo metastases). The recent introduction of effective systemic therapies, e.g. immune therapy, and technological advances enabling precise and effective radiotherapy, give hope that ablative therapy of metastases may lead to increased survival. The OLIGO project will offer ablative treatment for patients with oligometastatic disease across cancer diagnoses. We will prospectively collect data on treatment, safety and disease development.
The project will demand a lot of coordination and preparation. Meetings across the Danish Multidisciplinary Cancer Groups, writing of a scientific protocol incl. translational research, building of a scientific database and negotiation of legal collaboration contracts between departments.
Multidisciplinary organisation
DCCC Radiotherapy – The Danish National Research Center
Project stakeholder
- Gitte Fredberg Persson, Chief Physician, Department of Oncology, Herlev Hospital and Clinical Research Lecturer, University of Copenhagen. Primary contact, e-mail: gitte.persson@regionh.dk
- Azza Khalil, MD, PhD, Department of Oncology, Aarhus University Hospital
- Mette van Overeem Felter, ward doctor, department of cancer treatment, Herlev Hospital
- Tine Schytte, chief physician PhD clinical associate professor, oncology department Odense University Hospital
- Søren Møller, chief physician, Oncology Clinic, Rigshospitalet
- Henriette Lindberg, Chief Physician PhD, Department of Cancer Treatment, Herlev Hospital
- Lise Bentzen, chief physician, PhD, clinical associate professor, Aarhus University Hospital
- Charlotte Kristiansen, chief physician, oncology department, Lillebælt Vejle Hospital
- Laurids Østergaard Poulsen, MD, PhD, Department of Oncology, Aalborg University Hospital
- Jimmy Sønderggard, MD, PhD, Department of Oncology, Aalborg University Hospital
- Eva Serup-Hansen, MD, PhD, Department of Cancer Treatment, Herlev Hospital
- Maja Maraldo, PhD, Department of Oncology, Rigshospitalet
- Trine Lignell Guldberg, MD, PhD, Department of Oncology, Aalborg University Hospital